Erratum: Macrophage control of phagocytosed mycobacteria is increased by factors secreted by alveolar epithelial cells through nitric oxide independent mechanisms (PLoSONE (2014) 9:8 (e103411) DOI:10.1371/journal.pone.0103411);Macrophage control of phagocytosed mycobacteria is increased by factors secreted by alveolar epithelial cells through nitric oxide independent mechanisms

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Petursdottir, Dagbjort H ^a   Chuquimia, Olga D ^a   Freidl, Raphaela ^a   Fernández, Carmen ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING; SOCS1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; CELL DESTRUCTION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RESPIRATORY BURST; UPREGULATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTRACELLULAR SPACE; LUNG ALVEOLUS CELL; MACROPHAGE; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; PHAGOCYTOSIS; PHAGOSOME; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; BONE MARROW CELLS; CHLOROQUINE; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTRACELLULAR SPACE; MACROPHAGES; MICE, INBRED C57BL; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHAGOCYTOSIS; PHAGOSOMES; PNEUMOCYTES; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84905460187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108198     Document Type: Erratum

References (48)

1. Fehrenbach H (2012) Alveolar epithelial type II cells from embryonic stem cells: Knights in shining armour? Eur Respir J 39: 240-241.
2. Debbabi H, Ghosh S, Kamath AB, Alt J, Demello DE, et al. (2005) Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells. Am J Physiol Lung Cell Mol Physiol 289: L274-9. (Pubitemid 41008910)
3. Pechkovsky DV, Goldmann T, Ludwig C, Prasse A, Vollmer E, et al. (2005) CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II. Respir Res 6: 75.
4. Lo B, Hansen S, Evans K, Heath JK, Wright JR (2008) Alveolar epithelial type II cells induce T cell tolerance to specific antigen. J Immunol 180: 881-888.
5. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, et al. (2004) Primary human alveolar type II epithelial cell chemokine release: Effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 30: 500-509. (Pubitemid 38457183)
6. Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, et al. (2007) Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol 178: 463-473. (Pubitemid 46033630)
7. Chuquimia OD, Petursdottir DH, Periolo N, Fernandez C (2013) Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth. Infect Immun 81: 381-389.
8. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol 11: 750-761.
9. Cassetta L, Cassol E, Poli G (2011) Macrophage polarization in health and disease. ScientificWorldJournal 11: 2391-2402.
10. Biswas SK, Chittezhath M, Shalova IN, Lim JY (2012) Macrophage polarization and plasticity in health and disease. Immunol Res 53: 11-24.
11. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13: 453-461. (Pubitemid 351599757)
12. Vereyken EJ, Heijnen PD, Baron W, de Vries EH, Dijkstra CD, et al. (2011) Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J Neuroinflammation 8: 58-2094-8-58.
13. Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292.
14. Brysha M, Zhang JG, Bertolino P, Corbin JE, Alexander WS, et al. (2001) Suppressor of cytokine signaling-1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo. J Biol Chem 276: 22086-22089.
15. Humphreys IR, Stewart GR, Turner DJ, Patel J, Karamanou D, et al. (2006) A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect 8: 1339-1346. (Pubitemid 43842003)
16. Chuquimia OD, Petursdottir DH, Rahman MJ, Hartl K, Singh M, et al. (2012) The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: Communication between innate and adaptive immune systems. PLoS One 7: e32125.
17. Rahman MJ, Chuquimia OD, Petursdottir DH, Periolo N, Singh M, et al. (2011) Impact of toll-like receptor 2 deficiency on immune responses to mycobacterial antigens. Infect Immun 79: 4649-4656.
18. Corti M, Brody AR, Harrison JH (1996) Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol 14: 309-315. (Pubitemid 126440495)
19. Carow B, Ye X, Gavier-Widen D, Bhuju S, Oehlmann W, et al. (2011) Silencing suppressor of cytokine signaling-1 (SOCS1) in macrophages improves mycobacterium tuberculosis control in an interferon-gamma (IFN-gamma)-dependent manner. J Biol Chem 286: 26873-26887.
20. Zhang X, Goncalves R, Mosser DM (2008) The isolation and characterization of murine macrophages. Curr Protoc Immunol Chapter 14: Unit 14.1.
21. Rothfuchs AG, Gigliotti D, Palmblad K, Andersson U, Wigzell H, et al. (2001) IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol 167: 6453-6461. (Pubitemid 33081579)
22. Barrera LF, Kramnik I, Skamene E, Radzioch D (1994) Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-gamma and infection with BCG. Immunology 82: 457-464. (Pubitemid 24251631)
23. Sato K, Akaki T, Tomioka H (1998) Differential potentiation of antimycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha). Clin Exp Immunol 112: 63-68. (Pubitemid 28157100)
24. Flesch IE, Kaufmann SH (1991) Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: Role of reactive nitrogen intermediates. Infect Immun 59: 3213-3218.
25. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, et al. (1999) SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608. (Pubitemid 29418951)
26. Bronte V, Zanovello P (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5: 641-654. (Pubitemid 41113195)
27. Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, et al. (2012) TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37: 223-234.
28. Ehrt S, Schnappinger D (2009) Mycobacterial survival strategies in the phagosome: Defence against host stresses. Cell Microbiol 11: 1170-1178.
29. Yu K, Mitchell C, Xing Y, Magliozzo RS, Bloom BR, et al. (1999) Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber Lung Dis 79: 191-198. (Pubitemid 29446005)
30. Gwinn MR, Vallyathan V (2006) Respiratory burst: Role in signal transduction in alveolar macrophages. J Toxicol Environ Health B Crit Rev 9: 27-39. (Pubitemid 43068297)
31. Alvarez E, Leiro J, Orallo F (2002) Effect of (-)-epigallocatechin-3- gallate on respiratory burst of rat macrophages. Int Immunopharmacol 2: 849-855. (Pubitemid 34603130)
32. Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181: 3733-3739.
33. Taub DD, Key ML, Clark D, Turcovski-Corrales SM (1995) Chemotaxis of T lymphocytes on extracellular matrix proteins. analysis of the in vitro method to quantitate chemotaxis of human T cells. J Immunol Methods 184: 187-198.
34. Tschernig T, Pabst R (2009) What is the clinical relevance of different lung compartments? BMC Pulm Med 9: 39-2466-9-39.
35. Laskin DL, Weinberger B, Laskin JD (2001) Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 70: 163-170. (Pubitemid 32751506)
36. Schneberger D, Aharonson-Raz K, Singh B (2011) Monocyte and macrophage heterogeneity and toll-like receptors in the lung. Cell Tissue Res 343: 97-106.
37. Steinmuller C, Franke-Ullmann G, Lohmann-Matthes ML, Emmendorffer A (2000) Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: Comparison between rat alveolar and interstitial lung macrophages. Am J Respir Cell Mol Biol 22: 481-490. (Pubitemid 30343347)
38. Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G (1994) Pulmonary macrophages. Eur Respir J 7: 1678-1689. (Pubitemid 24294256)
39. Gordon SB, Read RC (2002) Macrophage defences against respiratory tract infections. Br Med Bull 61: 45-61. (Pubitemid 34477555)
40. Gordon S, Martinez FO (2010) Alternative activation of macrophages: Mechanism and functions. Immunity 32: 593-604.
41. Mantovani A, Locati M (2009) Orchestration of macrophage polarization. Blood 114: 3135-3136.
42. Anders HJ, Ryu M (2011) Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80: 915-925.
43. Orme J, Mohan C (2012) Macrophage subpopulations in systemic lupus erythematosus. Discov Med 13: 151-158.
44. Edwards JP, Zhang X, Frauwirth KA, Mosser DM (2006) Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80: 1298-1307. (Pubitemid 44904968)
45. Sironi M, Martinez FO, D'Ambrosio D, Gattorno M, Polentarutti N, et al. (2006) Differential regulation of chemokine production by fcgamma receptor engagement in human monocytes: Association of CCL1 with a distinct form of M2 monocyte activation (M2b, type 2). J Leukoc Biol 80: 342-349. (Pubitemid 44835507)
46. Lefevre L, Lugo-Villarino G, Meunier E, Valentin A, Olagnier D, et al. (2013) The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to leishmania infantum. Immunity 38: 1038-1049.
47. Hibbs JB,Jr, Vavrin Z, Taintor RR (1987) L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138: 550-565. (Pubitemid 17002220)
48. Whyte CS, Bishop ET, Ruckerl D, Gaspar-Pereira S, Barker RN, et al. (2011) Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol 90: 845-854.